![The Times Of India on Twitter: "Endless list of Omicron symptoms: Headache, runny nose, diarrhoea https://t.co/p0Lg8Mu7sJ https://t.co/oeluDTEM3d" / Twitter The Times Of India on Twitter: "Endless list of Omicron symptoms: Headache, runny nose, diarrhoea https://t.co/p0Lg8Mu7sJ https://t.co/oeluDTEM3d" / Twitter](https://pbs.twimg.com/media/FJcImn_aUAAp9xg.png)
The Times Of India on Twitter: "Endless list of Omicron symptoms: Headache, runny nose, diarrhoea https://t.co/p0Lg8Mu7sJ https://t.co/oeluDTEM3d" / Twitter
![Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England | Nature Communications Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-022-34244-2/MediaObjects/41467_2022_34244_Fig4_HTML.png)
Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England | Nature Communications
![Omicron survives longer on plastic, skin than prior variants; nose swabbing found best for rapid tests | Reuters Omicron survives longer on plastic, skin than prior variants; nose swabbing found best for rapid tests | Reuters](https://www.reuters.com/resizer/Z0xtYOJu5SPJUrY4UIz5DY-_0tQ=/1920x1005/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/VWKRJME2W5L6ZJJWCZJWGMYHLI.jpg)
Omicron survives longer on plastic, skin than prior variants; nose swabbing found best for rapid tests | Reuters
![Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England | Nature Communications Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-34244-2/MediaObjects/41467_2022_34244_Fig1_HTML.png)
Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England | Nature Communications
![SARS-CoV-2 Omicron variant: recent progress and future perspectives | Signal Transduction and Targeted Therapy SARS-CoV-2 Omicron variant: recent progress and future perspectives | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-022-00997-x/MediaObjects/41392_2022_997_Fig1_HTML.png)